Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Asset Writedowns and Impairment (2021 - 2023)

Oncology Institute's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $2.0 million for Q4 2023.

  • For Q4 2023, Asset Writedowns and Impairment rose 2587.84% year-over-year to $2.0 million; the TTM value through Sep 2024 reached $2.0 million, up 1794.29%, while the annual FY2023 figure was $2.0 million, 324.37% up from the prior year.
  • Asset Writedowns and Impairment reached $2.0 million in Q4 2023 per TOI's latest filing, up from $33000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.0 million in Q4 2023 to a low of -$722000.0 in Q2 2021.
  • Average Asset Writedowns and Impairment over 3 years is $189000.0, with a median of $74000.0 recorded in 2022.
  • The largest YoY upside for Asset Writedowns and Impairment was 2587.84% in 2023 against a maximum downside of 102.86% in 2023.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $250000.0 in 2021, then crashed by 70.4% to $74000.0 in 2022, then surged by 2587.84% to $2.0 million in 2023.
  • Per Business Quant, the three most recent readings for TOI's Asset Writedowns and Impairment are $2.0 million (Q4 2023), $33000.0 (Q3 2023), and -$3000.0 (Q2 2023).